NGFR and central nervous system cancer: Since we have shown that neurotrophin binding is required for p75NTR-mediated glioma invasion [15], and the neurotrophin-binding mutant p75CRD130 does not undergo RIP, it would appear that RIP of p75NTR is required for glioma invasion.